Entrada Therapeutics Inc TRDA
NASDAQ · United States · Health Technology
$5.38-0.30 (-5.28%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-05 | -1.01 | -1.05 | +3.7% | $898.00K | -59.8% | -5.1%$7.24→$6.87 |
| Q1 2026 | 2026-05-07 | -0.95 | -1.06 | +10.4% | — | — | -57.3%$16.03→$6.84 |
| Q4 2025 | 2026-02-26 | -0.94 | -1.32 | +28.8% | — | — | -0.4%$11.98→$11.93 |
| Q3 2025 | 2025-11-06 | -1.06 | -1.04 | -1.9% | — | — | -0.4%$6.94→$6.91 |
| Q4 2023 | 2024-03-13 | -0.28 | -0.14 | -100.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.